We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KRRO Korro Bio Inc

1.00 (2.07%)
Mar 01 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 14,988
Bid Price 1.00
Ask Price 61.00
News -
Day High 51.00


52 Week Range


Day Low 47.45
Share Name Share Symbol Market Stock Type
Korro Bio Inc KRRO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.00 2.07% 49.30 19:00:00
Open Price Low Price High Price Close Price Previous Close
48.37 47.45 51.00 49.30 48.30
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
731 14,988 US$ 49.68 US$ 744,591 - 13.00 - 71.6007
Last Trade Type Quantity Price Currency
15:00:00 100 US$ 50.21 USD

Korro Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
37.08M 738.53k - 0 -81.58M -110.47 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Korro Bio News

Date Time Source News Article
2/27/202407:00GlobeNewswire Inc.Korro to Present at the TD Cowen 44th Annual Health Care..
1/18/202407:00GlobeNewswire Inc.Korro Bio Highlights Data for its Lead Program in Alpha-1..
1/09/202408:02Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
1/09/202408:00Edgar (US Regulatory)Form 8-K - Current report
1/04/202407:00GlobeNewswire Inc.Korro to Present at the 42nd Annual J.P. Morgan Healthcare..
12/25/202323:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
12/22/202315:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]
12/20/202315:44Edgar (US Regulatory)Form S-1/A - General form for registration of securities..
12/07/202307:00GlobeNewswire Inc.Korro Announces Selection of its First Development Candidate..
12/01/202315:07Edgar (US Regulatory)Form S-1/A - General form for registration of securities..
11/29/202315:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/29/202315:53Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No KRRO Message Board. Create One! See More Posts on KRRO Message Board See More Message Board Posts

Historical KRRO Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week51.1654.9846.0248.1422,869-1.86-3.64%
1 Month51.3669.81546.0254.7017,377-2.06-4.01%
3 Months48.4369.81538.746551.5725,1680.871.80%
6 Months13.0071.600713.0046.6345,66636.30279.23%
1 Year13.0071.600713.0046.6345,66636.30279.23%
3 Years13.0071.600713.0046.6345,66636.30279.23%
5 Years13.0071.600713.0046.6345,66636.30279.23%

Korro Bio Description

Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |